cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Kura Oncology Inc
6 own
13 watching
Current Price
$13.21
$-0.14
(-1.05%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
902.43M
52-Week High
52-Week High
19.93
52-Week Low
52-Week Low
9.49
Average Volume
Average Volume
0.92M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization902.43M
icon52-Week High19.93
icon52-Week Low9.49
iconAverage Volume0.92M
iconDividend Yield--
iconP/E Ratio--
What does the Kura Oncology Inc do?
Developing in-licensed protein inhibitors for solid tumors and blood cancers.
Read More
How much money does Kura Oncology Inc make?
News & Events about Kura Oncology Inc.
Zolmax
3 months ago
Shares of Kura Oncology, Inc. (NASDAQ:KURA Get Rating) have earned a consensus recommendation of Moderate Buy from the six brokerages that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and five have issued a buy ...
Globe Newswire
3 months ago
SAN DIEGO, March 01, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is...
Globe Newswire
3 months ago
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report fourth quarter and full year 2022 financial results ...
Globe Newswire
3 months ago
Phase 1 trial showed 30% CR rate among 20 NPM1-mutant AML patients treated at recommended Phase 2 dose Phase 2 registration-directed trial expected to enroll 85 patients in the U.S. and Europe SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage ...
Ticker Report
3 months ago
Kura Oncology, Inc. (NASDAQ:KURA Get Rating) has been assigned a consensus recommendation of Moderate Buy from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and six ...
Frequently Asked Questions
Frequently Asked Questions
What is Kura Oncology Inc share price today?
plus_minus_icon
Can Indians buy Kura Oncology Inc shares?
plus_minus_icon
How can I buy Kura Oncology Inc shares from India?
plus_minus_icon
Can Fractional shares of Kura Oncology Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Kura Oncology Inc stocks?
plus_minus_icon
What is today’s traded volume of Kura Oncology Inc?
plus_minus_icon
What is today’s market capitalisation of Kura Oncology Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Kura Oncology Inc?
plus_minus_icon
What percentage is Kura Oncology Inc down from its 52-Week High?
plus_minus_icon
What percentage is Kura Oncology Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$13.21
$-0.14
(-1.05%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Vericel Corporation
Vericel Corporation
$32.94
$-0.61 (-1.82 %)
Mesoblast
Mesoblast
$3.48
$-0.15 (-4.13 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$9.18
$-0.14 (-1.50 %)
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc.
$12.34
$-0.14 (-1.12 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Vericel Corporation
Vericel Corporation
$32.94
$-0.61 (-1.82 %)
Mesoblast
Mesoblast
$3.48
$-0.15 (-4.13 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$9.18
$-0.14 (-1.50 %)
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc.
$12.34
$-0.14 (-1.12 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00